24th Jan 2008 07:00
Tepnel Life Sciences PLC24 January 2008 FOR IMMEDIATE RELEASE Tepnel Life Sciences plc ('Tepnel' or 'the Company') Board appointment Manchester, U.K, 24 January 2008 Tepnel Life Sciences plc (AIM: TED), theinternational Molecular Diagnostics and Research Products & Services group, ispleased to announce the appointment of Michael Keith Slater, aged 33, as GroupFinance Director. Mr. Slater, ACA, joined Tepnel Life Sciences plc in October 2005 as GroupFinancial Controller and has been responsible for the financial and accountingaffairs of Tepnel since appointment. Prior to joining Tepnel, Mr Slater was aSenior Manager with KPMG, the international accountancy and professionalservices firm. Ben Matzilevich, Tepnel's Chief Executive Officer commented 'On behalf of theBoard of Directors I welcome Michael's appointment to the Board as Group FinanceDirector and am confident of his continued success in this position.' -Ends- For further information: Tepnel Life Sciences plcBen Matzilevich, CEOCarol SmithTel: 0161 946 2200 Capital MS&LMary Clark or Catie CorcoranTel: +44 20 7307 5330 Seymour Pierce LimitedMark PercyTel: +44 20 7107 8000 There are no further details required to be disclosed pursuant to schedule 2(g)of the AIM Rules. Notes to Editors: About Tepnel Life Sciences plc - Tepnel Life Sciences plc (AIM: TED) is aUK-based international life sciences products and services group with twodivisions, Molecular Diagnostics and Research Products & Services. The Companyhas laboratories, manufacturing and operations in the USA, UK and France with195 employees. Tepnel provides test kits, reagents and services to two highly synergisticmarkets, these being Molecular Diagnostics and Biomedical Research. The Company's strategy has been to identify high growth niche opportunitieswithin these multi-billion pound markets. Tepnel focuses on these opportunitieswith internally developed products, patents, expertise and know-how as well asstrategic acquisitions, to develop a leadership position within these definedmarket segments. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TED.L